You have 9 free searches left this month | for more free features.

stage IV mantle cell lymphoma

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Osteoarthritis, Knee Trial in Jakarta Pusat (Mesenchymal Stem Cells with Arthoscopy, Mesenchymal Stem Cells without Arthoscopy,

Recruiting
  • Osteoarthritis, Knee
  • Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome
  • +3 more
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Gatot Soebroto Hospital
Sep 25, 2022

Non Small Cell Lung Cancer Trial in Buffalo (SBRT)

Recruiting
  • Non Small Cell Lung Cancer
  • SBRT
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 27, 2022

Non-alcoholic Fatty Liver Disease, Liver Cirrhosis Trial in Worldwide (CC-90001, Placebo)

Terminated
  • Non-alcoholic Fatty Liver Disease
  • Liver Cirrhosis
  • Phoenix, Arizona
  • +121 more
Oct 19, 2021

Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )

Active, not recruiting
  • Vasovagal Syncope
  • midodrine hydrochloride
  • matching placebo
  • Minneapolis, Minnesota
  • +16 more
Nov 1, 2022

Neuromyelitis Optica Spectrum Disorder Trial in Barcelona (Ravulizumab)

Recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Barcelona, Spain
    Clinical Trial Site
Jul 6, 2022

Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in

Completed
  • Endometrial Cancer
  • Cervical Cancer
  • Indocyanine green-guided systematic pelvic lymphadenectomy
  • (no location specified)
Jan 29, 2023

Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

Active, not recruiting
  • Solid Tumor
  • +4 more
  • Nashville, Tennessee
  • +14 more
Jul 21, 2022

Pneumonia, Bacterial Trial (CAL02, Placebo)

Not yet recruiting
  • Pneumonia, Bacterial
  • (no location specified)
Mar 7, 2023

Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)

Recruiting
  • Hematopoietic Organs; Disorder
  • Total lymphoid irradiation
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Oct 4, 2023

Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy

Recruiting
  • Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jan 1, 2023

Vitiligo Trial in Worcester (Metformin Hydrochloride)

Not yet recruiting
  • Vitiligo
  • Metformin Hydrochloride
  • Worcester, Massachusetts
    UMass Chan Medical School
Nov 6, 2022

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Predictive Factor of Pathologic Complete Response After

Completed
  • Rectum Cancer
    • Bangkok, Bankok, Thailand
      Chairat Supsamutchai
    May 15, 2022

    Stem Cell Transplant Trial in Boston, Durham, Seattle (Palliative Care Intervention, Standard Transplant Care)

    Active, not recruiting
    • Stem Cell Transplant
    • Palliative Care Intervention
    • Standard Transplant Care
    • Boston, Massachusetts
    • +2 more
    Aug 23, 2022

    Hypertension, Vascular Diseases, Cardiovascular Diseases Trial in Worldwide (Paradise Renal Denervation System, Renal Angiogram)

    Active, not recruiting
    • Hypertension
    • +2 more
    • Paradise Renal Denervation System
    • Renal Angiogram
    • Birmingham, Alabama
    • +58 more
    Mar 28, 2022

    Molecules Associated With Progression of Prediabetes to Overt

    Recruiting
    • Type2 Diabetes Mellitus
    • Pre Diabetes
      • London, United Kingdom
        University of Roehampton
      May 17, 2022

      Parkinson Disease, Freezing of Gait Trial in Beijing (Vibrotactile foot device (Smart shoe))

      Recruiting
      • Parkinson Disease
      • Freezing of Gait
      • Vibrotactile foot device (Smart shoe)
      • Beijing, China
        Xuanwu Hospital
      Nov 21, 2023

      Classical Hodgkin Lymphoma Trial in Cologne (Brentuximab Vedotin)

      Recruiting
      • Classical Hodgkin Lymphoma
      • Brentuximab Vedotin
      • Cologne, Germany
        1st Department of Medicine, Cologne University Hospital
      Nov 26, 2020

      Melanoma Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab, Placebo)

      Terminated
      • Melanoma
      • Talimogene Laherparepvec
      • +2 more
      • Birmingham, Alabama
      • +160 more
      Nov 10, 2022

      Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)

      Recruiting
      • Sickle Cell Disease
      • Sickle Cell Anemia
      • Biotin label
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 11, 2022

      Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

      Not yet recruiting
      • Non-small Cell Lung Adenocarcinoma
      • Squamous Cell Carcinoma of Lung
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 5, 2023

      Esophageal Achalasia, Transcranial Magnetic Stimulation, Repetitive, Vagus Nerve Motor Disorder Trial in Nanjing (Repetitive

      Not yet recruiting
      • Esophageal Achalasia
      • +3 more
      • Repetitive transcranial magnetic stimulation
      • Sham
      • Nanjing, China
        Nanjing Drum Tower Hospital
      Sep 6, 2023

      Clinical and Laboratory Analysis of Familial Cancer

      Completed
      • Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        May 12, 2022

        HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

        Recruiting
        • HIV-1-infection
        • INO-6160, 2 mg
        • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
        • New York, New York
        • +2 more
        Apr 13, 2023

        Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)

        Completed
        • Head and Neck Squamous Cell Carcinoma
        • Shreveport, Louisiana
        • +3 more
        Oct 3, 2023